心衰患者-话题@MedSci

#心衰患者#

341篇内容 | 2183人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1373554, encodeId=3eec13e355449, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=Eur Heart J：恩格列净对不同射血分数心衰患者的影响, objectType=article, longId=221837, objectId=10d222183e97, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10d222183e97, replyNumber=0, likeNumber=39, createdTime=2021-12-12, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10d222183e97, moduleTitle=Eur Heart J：恩格列净对不同射血分数心衰患者的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10d222183e97)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373553, encodeId=d3ff13e35537b, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=新定义！血钾＞5.0 mmol/L为高钾血症！心衰患者高钾血症怎么治？, objectType=article, longId=221274, objectId=884a2212e4f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=884a2212e4f1, replyNumber=0, likeNumber=40, createdTime=2021-12-01, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=884a2212e4f1, moduleTitle=新定义！血钾＞5.0 mmol/L为高钾血症！心衰患者高钾血症怎么治？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=884a2212e4f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373552, encodeId=e4bf13e35525f, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=JACC：停用β受体阻滞剂可改善心衰患者的运动能力, objectType=article, longId=220930, objectId=528e220930b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=528e220930b4, replyNumber=0, likeNumber=47, createdTime=2021-11-25, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=528e220930b4, moduleTitle=JACC：停用β受体阻滞剂可改善心衰患者的运动能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=528e220930b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373551, encodeId=494913e355130, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=AHA 2021：全球首项“虚拟”临床试验CHIEF-HF结果揭晓！无论射血分数如何、有无糖尿病，卡格列净均能改善心衰患者症状, objectType=article, longId=220604, objectId=ebba22060462, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebba22060462, replyNumber=0, likeNumber=48, createdTime=2021-11-20, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebba22060462, moduleTitle=AHA 2021：全球首项“虚拟”临床试验CHIEF-HF结果揭晓！无论射血分数如何、有无糖尿病，卡格列净均能改善心衰患者症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebba22060462)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373550, encodeId=c87e13e35501e, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=Circulation：射血分数正常的心衰患者恩格列净、健康状态和生活质量, objectType=article, longId=220474, objectId=fbdf2204e435, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbdf2204e435, replyNumber=0, likeNumber=42, createdTime=2021-11-18, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbdf2204e435, moduleTitle=Circulation：射血分数正常的心衰患者恩格列净、健康状态和生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbdf2204e435)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373549, encodeId=6d5213e35494e, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=JAHA：急性失代偿性心衰患者缺血性卒中, objectType=article, longId=219182, objectId=65a9219182c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65a9219182c4, replyNumber=0, likeNumber=38, createdTime=2021-10-26, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65a9219182c4, moduleTitle=JAHA：急性失代偿性心衰患者缺血性卒中, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65a9219182c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373548, encodeId=53be13e35484e, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=JAHA：射血分数正常与射血分数降低的心衰患者再入院、死亡及其相关预测因素, objectType=article, longId=219031, objectId=d1af219031db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1af219031db, replyNumber=0, likeNumber=38, createdTime=2021-10-23, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1af219031db, moduleTitle=JAHA：射血分数正常与射血分数降低的心衰患者再入院、死亡及其相关预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1af219031db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373547, encodeId=9a6d13e35477e, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=Lancet：人工智能重新定义，倍他乐克是治疗年轻房颤心衰患者的“基石”！, objectType=article, longId=218929, objectId=dba82189299a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dba82189299a, replyNumber=0, likeNumber=51, createdTime=2021-10-22, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dba82189299a, moduleTitle=Lancet：人工智能重新定义，倍他乐克是治疗年轻房颤心衰患者的“基石”！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dba82189299a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373546, encodeId=d2d013e3546dc, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=Circulation：恩格列净对射血分数保留的心衰患者心衰事件恶化的效益, objectType=article, longId=218892, objectId=3a1021889230, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a1021889230, replyNumber=0, likeNumber=42, createdTime=2021-10-21, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a1021889230, moduleTitle=Circulation：恩格列净对射血分数保留的心衰患者心衰事件恶化的效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a1021889230)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373545, encodeId=350313e35454d, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=NEJM：射血分数正常的心衰患者恩格列净治疗效果, objectType=article, longId=218562, objectId=6a0321856290, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a0321856290, replyNumber=0, likeNumber=31, createdTime=2021-10-15, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a0321856290, moduleTitle=NEJM：射血分数正常的心衰患者恩格列净治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a0321856290)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373544, encodeId=64e713e35442d, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=JAHA：循环miR-19b-3p作为急性心衰患者新型预后生物标志物, objectType=article, longId=218207, objectId=651a21820ea2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=651a21820ea2, replyNumber=0, likeNumber=54, createdTime=2021-10-09, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=651a21820ea2, moduleTitle=JAHA：循环miR-19b-3p作为急性心衰患者新型预后生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=651a21820ea2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373543, encodeId=ae3b13e3543fa, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=JAHA：循环和心肌细胞因子可预测接受机械循环支持的心衰患者心脏结构和功能改善, objectType=article, longId=218073, objectId=203a2180e3c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=203a2180e3c1, replyNumber=0, likeNumber=57, createdTime=2021-10-04, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=203a2180e3c1, moduleTitle=JAHA：循环和心肌细胞因子可预测接受机械循环支持的心衰患者心脏结构和功能改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=203a2180e3c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373542, encodeId=290813e354224, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=JACC：NT-proBNP水平越高，心衰患者预后越差！, objectType=article, longId=218058, objectId=c6f021805838, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6f021805838, replyNumber=0, likeNumber=42, createdTime=2021-10-04, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6f021805838, moduleTitle=JACC：NT-proBNP水平越高，心衰患者预后越差！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6f021805838)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373541, encodeId=3db813e3541b8, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=JAHA：卡维地洛与美托洛尔对伴有和不伴有2型糖尿病的心衰患者长期死亡率影响的比较, objectType=article, longId=217261, objectId=f28c21e26102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f28c21e26102, replyNumber=0, likeNumber=44, createdTime=2021-09-19, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f28c21e26102, moduleTitle=JAHA：卡维地洛与美托洛尔对伴有和不伴有2型糖尿病的心衰患者长期死亡率影响的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f28c21e26102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373540, encodeId=395113e354075, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=Cardiovasc Diabetol：卡格列净对2型糖尿病合并慢性心衰患者NT-proBNP水平的影响, objectType=article, longId=217248, objectId=505d21e2487a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=505d21e2487a, replyNumber=0, likeNumber=34, createdTime=2021-09-19, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=505d21e2487a, moduleTitle=Cardiovasc Diabetol：卡格列净对2型糖尿病合并慢性心衰患者NT-proBNP水平的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=505d21e2487a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373539, encodeId=40e813e35390a, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=JACC：老年心衰患者植入左心室辅助装置(LVAD)后的临床预后, objectType=article, longId=216625, objectId=5d7d21662574, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d7d21662574, replyNumber=0, likeNumber=50, createdTime=2021-09-04, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d7d21662574, moduleTitle=JACC：老年心衰患者植入左心室辅助装置(LVAD)后的临床预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d7d21662574)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373538, encodeId=acf613e3538f2, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=张健教授点评：GUIDE-HF研究——早期心衰患者或将从血流动力学检测中得到更多获益, objectType=article, longId=216475, objectId=b4862164e52c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4862164e52c, replyNumber=0, likeNumber=43, createdTime=2021-09-01, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4862164e52c, moduleTitle=张健教授点评：GUIDE-HF研究——早期心衰患者或将从血流动力学检测中得到更多获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4862164e52c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373537, encodeId=cc5313e3537e9, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=Circulation：Vericiguat对射血分数降低心衰患者血红蛋白和临床结局的影响, objectType=article, longId=216451, objectId=4882216451d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4882216451d9, replyNumber=0, likeNumber=30, createdTime=2021-08-31, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4882216451d9, moduleTitle=Circulation：Vericiguat对射血分数降低心衰患者血红蛋白和临床结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4882216451d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373536, encodeId=bede13e35364d, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=Age & Ageing：老年心衰患者如何控制血压才能很大程度降低死亡风险？, objectType=article, longId=214390, objectId=a18221439027, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a18221439027, replyNumber=0, likeNumber=44, createdTime=2021-07-20, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a18221439027, moduleTitle=Age & Ageing：老年心衰患者如何控制血压才能很大程度降低死亡风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a18221439027)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1373535, encodeId=876013e3535c6, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, objectTitle=JACC：射血分数对使用奥美拉唑治疗改善心衰患者心功能结果的影响, objectType=article, longId=214175, objectId=b6b62141e566, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6b62141e566, replyNumber=0, likeNumber=27, createdTime=2021-07-15, rootId=0, userName=yuanming7, userId=467c360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6b62141e566, moduleTitle=JACC：射血分数对使用奥美拉唑治疗改善心衰患者心功能结果的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6b62141e566)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

心衰患者

2020-05-29

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

Eur Heart J：恩格列净对不同射血分数心衰患者的影响

2021-12-12

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

新定义！血钾＞5.0 mmol/L为高钾血症！心衰患者高钾血症怎么治？

2021-12-01

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

JACC：停用β受体阻滞剂可改善心衰患者的运动能力

2021-11-25

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

AHA 2021：全球首项“虚拟”临床试验CHIEF-HF结果揭晓！无论射血分数如何、有无糖尿病，卡格列净均能改善心衰患者症状

2021-11-20

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

Circulation：射血分数正常的心衰患者恩格列净、健康状态和生活质量

2021-11-18

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

JAHA：急性失代偿性心衰患者缺血性卒中

2021-10-26

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

JAHA：射血分数正常与射血分数降低的心衰患者再入院、死亡及其相关预测因素

2021-10-23

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

Lancet：人工智能重新定义，倍他乐克是治疗年轻房颤心衰患者的“基石”！

2021-10-22

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

Circulation：恩格列净对射血分数保留的心衰患者心衰事件恶化的效益

2021-10-21

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

NEJM：射血分数正常的心衰患者恩格列净治疗效果

2021-10-15

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

JAHA：循环miR-19b-3p作为急性心衰患者新型预后生物标志物

2021-10-09

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

JAHA：循环和心肌细胞因子可预测接受机械循环支持的心衰患者心脏结构和功能改善

2021-10-04

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

JACC：NT-proBNP水平越高，心衰患者预后越差！

2021-10-04

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

JAHA：卡维地洛与美托洛尔对伴有和不伴有2型糖尿病的心衰患者长期死亡率影响的比较

2021-09-19

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

Cardiovasc Diabetol：卡格列净对2型糖尿病合并慢性心衰患者NT-proBNP水平的影响

2021-09-19

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

JACC：老年心衰患者植入左心室辅助装置(LVAD)后的临床预后

2021-09-04

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

张健教授点评：GUIDE-HF研究——早期心衰患者或将从血流动力学检测中得到更多获益

2021-09-01

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

Circulation：Vericiguat对射血分数降低心衰患者血红蛋白和临床结局的影响

2021-08-31

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

Age & Ageing：老年心衰患者如何控制血压才能很大程度降低死亡风险？

2021-07-20

yuanming7 (审核中...)

前往app查看评论内容

#心衰患者#

JACC：射血分数对使用奥美拉唑治疗改善心衰患者心功能结果的影响

2021-07-15

科室
- - 订阅+
  - 更多科室
工具
服务